50 million doses of Covaxin set to expire in early 2023 due to poor demand
By PTI HYDERABAD: Nearly 50 million doses of Bharat Biotech’s COVID-19 vaccine, Covaxin lying with the firm are set to expire early next year...
Covaxin
Government nod for Corbevax as booster for adults vaccinated with Covishield, Covaxin soon
4 min read
By PTI NEW DELHI: The Union health ministry is expected to soon approve Biological E’s Corbevax as a precaution dose for people above 18...
Covaxin booster safe, necessary as it ensures persistent immunity: ICMR study
By Express News Service NEW DELHI: The Covaxin booster dose is safe and necessary as it ensures persistent immunity that minimises breakthrough Covid infections,...
Immunisation body likely to consider Corbevax as booster for those jabbed with Covishield, Covaxin
1 min read
By PTI NEW DELHI: Allowing Biological E’s Corbevax as a booster for those fully vaccinated against COVID-19 with either Covishield or Covaxin is likely...
DCGI to review Serum Institute’s applications for Covovax use in kids aged 2 to 7 yrs, 7 to 11 yrs
2 min read
By PTI NEW DELHI: The subject expert committee on COVID-19 of India’s drug regulator will on Friday review the applications of Serum Institute of...
Covaxin booster dose enhances vaccine effectiveness against Delta, Omicron variants, says ICMR study
2 min read Covaxin booster dose enhances vaccine effectiveness against Delta, Omicron variants, says ICMR study
By PTI NEW DELHI: The administration of Covaxin as a booster dose enhances vaccine effectiveness against COVID-19’s Delta variant and gives protection against Omicron...
Bharat Biotech’s Covaxin gets emergency approval for 6-12 age group
By PTI NEW DELHI: Bharat Biotech International Ltd (BBIL) on Tuesday said its COVID-19 vaccine, Covaxin, has received emergency use approval in children 6-12...
DCGI grants EUA to Corbevax for those aged 5-12, Covaxin for 6-12 age group
By PTI NEW DELHI: India’s drug regulator has granted emergency use authorisation for Biological E’s COVID-19 vaccine Corbevax for those aged five to 12...
Covaxin’s phase 2/3 clinical trials put on hold in the US
Express News Service NEW DELHI: The US Food and Drug Administration (FDA) has put on hold the phase 2/3 clinical trials of Bharat Biotech’s...
US FDA puts Covaxin’s second phase trials in US on hold after fallout on WHO’s observations
2 min read
By PTI HYDERABAD: The US Food and Drug Administration has put on hold the phase 2/3 clinical trials of Bharat Biotech’s COVID-19 vaccine Covaxin,...
“They tried to classify women into different classes”: PM Modi slams Opposition in Gujarat 
Over 5.6 crore hospital admissions worth Rs. 69,000 crore under PM-JAY scheme: Mandaviya 
New museum inaugurated in Bhopal with the installation of statues of Chief Ministers : CM Shri Chouhan 
Indo-Pacific facing complex web of security challenges, says Rajnath at conference of army chiefs